Skip to content

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00549952
Enrollment
Unknown
Registered
2007-10-26
Start date
2007-10-31
Completion date
2008-03-31
Last updated
2007-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Mucositis

Brief summary

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Interventions

Sponsors

Otsuka Pharmaceutical Co., Ltd.
CollaboratorINDUSTRY
Korea Otsuka Pharmaceutical Co., Ltd.
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion criteria

* Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential * Patients with performance status of ECOG score is more than 3

Design outcomes

Primary

MeasureTime frame
incidence and severity of oral mucositis

Countries

South Korea

Contacts

Primary ContactYonghui Jeong
jeongyh@otsuka.co.kr82-2-3465-3956
Backup ContactBoyoun Seo
byseo@otsuka.cokr82-2-3465-5485

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026